Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization. - Wikidata - awgldk - TriplyDB

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

http://www.wikidata.org/entity/Q34039409

about

Targeting Notch to overcome radiation resistance Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy Combining radiotherapy with sunitinib: lessons (to be) learned Improving the efficacy of chemoradiation with targeted agents The impact of the myeloid response to radiation therapy Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy Microbubble and ultrasound radioenhancement of bladder cancer.Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts Modeling Longitudinal Preclinical Tumor Size Data to Identify Transient Dynamics in Tumor Response to Antiangiogenic Drugs Role of HIF-1α in response of tumors to a combination of hyperthermia and radiation in vivo.Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future.Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth.Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.Anti-VEGF antibodies mitigate the development of radiation necrosis in mouse brain.BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation.The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.Effect of Avastin on the number and structure of tumor blood vessels of nude mice with A549 lung adenocarcinoma.Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor.Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer.Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancer.Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven Evaluation of hypoxia in a feline model of head and neck cancer using ⁶⁴Cu-ATSM positron emission tomography/computed tomography.Combination therapy of VEGF-trap and gemcitabine results in improved anti-tumor efficacy in a mouse lung cancer model Tumour thermotolerance, a physiological phenomenon involving vessel normalisation Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice.

P2860

Q26771701-C566C224-7766-4633-8F62-A3C8904F3BCF Q26777016-1F523366-CCBE-4525-89B6-A89B6286C7CF Q26800587-96D2A24B-5041-4817-A709-29FE69C16FFD Q26850193-38CD2CD5-A8CF-4ECC-9D22-863B9064A4C8 Q26851643-2D6D60C1-09E0-4B26-885F-32A995A25825 Q26991865-B8980D45-B64A-4AF8-848B-63B45EF42FD5 Q27025579-3362BC0B-98CF-48B3-89E6-9251668A4487 Q27300346-85DA8599-DAA7-44AB-A5AE-CE1334F5A8A1 Q28086904-685A07D9-8DD4-442A-9717-7A635FCD46B0 Q30451819-21B85CC2-6BF6-4087-91A1-63FCC5E1EB78 Q30469815-013581F8-4668-4259-A516-D45967186779 Q30471456-39536330-1396-4E87-9146-BCB15AF83850 Q30855619-40693E71-3EF3-4DE3-8314-083936044274 Q31143294-326E24BE-6D78-4816-8A96-2C77B1C40706 Q32174462-E96866D8-C622-4F22-8FAD-AB938D3C9F1A Q33588739-071D6175-07A3-4AAB-B39E-4F4503034E9E Q33705268-46B37093-4F7E-403A-94B4-90F87E45360F Q33732629-F06E435D-FE47-4C73-95FE-D7A93E676732 Q33756489-B50AB58B-09E5-462D-85D5-BEB752810387 Q33769521-862E1146-6E5B-4463-B4FC-0DB0136BA55E Q33834316-36A48C94-C760-49E3-A73E-749C7659E7D3 Q33920350-32165DF1-6255-4C9F-BC73-2ADFE8B235C7 Q34054649-7E9EA52A-4EEB-4940-8A23-D00D5DC30528 Q34059649-9A43D556-7C80-43D8-8700-90A1FD7CB5AC Q34075597-CDD8B2E0-975C-4EC8-8932-D1F9E978F6DE Q34230220-868D901F-ABAC-47D3-B671-D30136B5A7E5 Q34348199-81C55C70-3FB2-40CA-BDB3-122ADF0DFDB3 Q34443953-562F82EB-4A80-42BD-AB88-34D8BC4AE525 Q34470585-CC6CD496-0E06-4025-A49C-916694F3E9AB Q34564173-900BA324-9F8F-4670-9076-52C6741201DD Q34564225-DE845547-DDC1-4B5D-867F-15DC43FD9B7D Q34564433-81B704F4-D766-4DBB-9922-055D86D0DDC6 Q34589227-8AAF8F69-68E6-4FE2-A38C-03C08555F42F Q34696310-E91C6BE3-21EA-4CCA-BBC3-8CB29417884F Q34849516-A5B14185-189B-4225-981B-EA022EEC7104 Q34916042-3E60587B-F420-4DBF-9BF5-C8DC69F182CE Q35042985-FD60436C-2D62-4CA4-B7A0-BE0C6F8F43D3 Q35165488-E5735940-7AD5-4F33-BCF5-496D946DD248 Q35570253-79303644-D20F-410B-92F5-2A6D49D36D6D Q35758084-979BE971-E85A-4041-AF8D-454D9D05AFF2

P2860

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

http://www.wikidata.org/entity/Q34039409

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Scheduling of radiation with a ...... come via vessel normalization.

@ast

Scheduling of radiation with a ...... come via vessel normalization.

@en

Scheduling of radiation with a ...... come via vessel normalization.

@nl

type

label

Scheduling of radiation with a ...... come via vessel normalization.

@ast

Scheduling of radiation with a ...... come via vessel normalization.

@en

Scheduling of radiation with a ...... come via vessel normalization.

@nl

prefLabel

Scheduling of radiation with a ...... come via vessel normalization.

@ast

Scheduling of radiation with a ...... come via vessel normalization.

@en

Scheduling of radiation with a ...... come via vessel normalization.

@nl

P1433

Q34039409-FF17F951-C79C-4E6D-8552-F9F5D2769B95

P1476

Q34039409-2DD0BE00-E71C-418C-83FD-8A40223A7807

P2093

Q34039409-0869E329-4DE6-40CA-853C-A672DE4B984F

Q34039409-0B49D936-D6FF-4150-AD89-9C18F16E1B11

Q34039409-ADDD10B8-36C4-4B63-B05C-7E80591E5BFF

Q34039409-B246C765-F356-471B-8893-722A78B19FA8

Q34039409-B4A1B096-3F8F-4693-93B8-D3AD69A9BD8A

Q34039409-FB590AF8-F02C-43BD-B53A-8FF9F9D7C801

P2860

Q34039409-034AD26D-B85F-43CC-85B1-5A3FCE24D955

Q34039409-09C87A1B-F904-46A8-96BE-A44524E61818

Q34039409-12BBA037-B618-42B8-B885-BD40FF6BFC38

Q34039409-1A1BC55E-9264-4A16-B815-D8CF5ACB8CB1

Q34039409-20458EA7-9024-4BB9-BB50-E627D88758D3

Q34039409-238F782A-692A-4978-9904-5CD7D2FFDB43

Q34039409-2D8CA8CA-BC68-47DD-BCEB-68A8A65A0705

Q34039409-351D33EB-EB8B-4691-A5A2-D389EDC81AB1

Q34039409-3E13E9A2-DC3B-455F-8D87-5776C0284EDC

Q34039409-3EF4CF31-7A09-4880-AF5D-81089EC6CC21

P304

Q34039409-1CA3969F-7A08-4C88-AD54-608DF7FD4385

P31

Q34039409-6FAA5BBA-4D25-4998-AA1A-B933710EEA41

P356

Q34039409-A1F4634F-368B-4160-9E2F-E0AABB272E25

P407

Q34039409-F8D0566D-6C18-4563-A5DE-CE8067999E00

P433

Q34039409-1379E4C6-5FF7-4EF8-9AB4-06F1B3B44E69

P478

Q34039409-C2095CE7-7E83-4951-B237-505D36B2B1CA

P50

Q34039409-CC88F05E-13BB-4EE2-93C8-BD881C22D223

P577

Q34039409-BFEEA246-3C29-4F33-8123-697D0408435D

P5875

Q34039409-6ACD4ED4-9B38-4D57-BBC1-D074F0DF3D57

P698

Q34039409-060F3E72-AE1D-4228-AF17-900C5C442608

P932

Q34039409-FFE2F8AB-E077-4A63-AE60-07913EA56CDB

P356

1078-0432.CCR-06-2441

P1433

Clinical Cancer Research

P1476

Scheduling of radiation with a ...... tcome via vessel normalization

@en

P2093

Arjan W Griffioen

http://www.w3.org/2001/XMLSchema#string

Elizabeth McNiel

http://www.w3.org/2001/XMLSchema#string

Hanke Heun

http://www.w3.org/2001/XMLSchema#string

Kevin H Mayo

http://www.w3.org/2001/XMLSchema#string

Melissa Loren

http://www.w3.org/2001/XMLSchema#string

Robert J Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548] combined with ionizing radiation on endothelial cells and tumour growth

The biology of vascular endothelial growth factor

Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density.

Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment.

Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities.

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

P304

3395-3402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-2441

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6290121

http://www.w3.org/2001/XMLSchema#string

P698

17545548

http://www.w3.org/2001/XMLSchema#string

P932

2914684

http://www.w3.org/2001/XMLSchema#string